MP

MEGAN PEREZ BURKE

THE PETRIZZO GROUP, INC. · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
6
last 3 years
Filings
17
4 agencies contacted
Activity
filings by quarter
Works on

Background

Government experience
Legislative Director
Health Policy Director to Congresswoman Cathy McMorris Rodgers
Disclosed on LD-2 filings
Legislative Director
Health Policy Director for Congresswoman Cathy McMorris Rodgers
Disclosed on LD-2 filings
Legislative Director
Health Policy Advisor for Congresswoman Cathy McMorris Rodgers
Disclosed on LD-2 filings
Legislative Director
Health Policy Advisor to Congresswoman Cathy McMorris Rodgers
Disclosed on LD-2 filings
Legislative Director
Congresswoman Cathy McMorris Rodgers
Disclosed on LD-2 filings
Career
Washington, DC
2024 - present

Specific issues

Advocate for NIH research funding for dysautonomia disorders, specifically Postural Orthostatic Tachycardia Syndrome (POTS) and funding to examine the correlation between POTS and Long COVID. Supporting establishment of an infection associated chronic conditions office at the NIH to coordinate research. Asking for continued support for the Autonomic Medicine Section at the NIH.
Medical/Disease Research/Clinical Labs · 2024 Q3
Advocating for funding for (1) a public awareness and provider education program at the CDC on POTS and similar forms of dysautonomia, (2) an infection associated chronic conditions office at the NIH to coordinate research, and (3) funding for research to examine the correlation between POTS and Long COVID.
Budget/Appropriations · 2024 Q3
Advocating for policies to address access to patient care, including maintaining and increasing autonomic fellowships.
Health Issues · 2024 Q3
Advocating for expanded and equal access of telehealth use in healthcare -- Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act. Medicare Coverage of Innovative Technology (MCIT) - H.R. 1691, the Ensuring Patient Access to Critical Breakthrough Products Act. EtO Emissions Standards. PFAS regulation. Artificial intelligence regulation in healthcare, and the broader government.
Health Issues · 2024 Q3
Advocating for expanded and equal access of telehealth use in healthcare Medicare Coverage of Innovative Technology (MCIT) - H.R. 1691, the Ensuring Patient Access to Critical Breakthrough Products Act.
Medicare/Medicaid · 2024 Q3
S. 866: The American Innovation and Jobs Act H.R. 2673: The American Innovation and R&D Competitiveness Act of 2023
Taxation/Internal Revenue Code · 2024 Q3

Clients

$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock

Filing history

2024 Q3
NATIONAL DOWN SYNDROME SOCIETY
Q3lda.gov →
2024 Q3
SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION
Q3lda.gov →
2024 Q3
AMERICAN ASSOCIATION FOR HOMECARE
Q3lda.gov →
2024 Q3
DYSAUTONOMIA INTERNATIONAL
Q3lda.gov →
2024 Q3
MEDICAL ALLEY ASSOCIATION
Q3lda.gov →
2024 Q3
NORTH CAROLINA HEALTHCARE ASSOCIATION
Q3lda.gov →
2024 Q2
NORTH CAROLINA HEALTHCARE ASSOCIATION
Q2lda.gov →
2024 Q2
NORTH CAROLINA HEALTHCARE ASSOCIATION
RRlda.gov →
2024 Q3
AMERICAN ASSOCIATION FOR HOMECARE
RRlda.gov →
2024 Q2
DYSAUTONOMIA INTERNATIONAL
Q2lda.gov →
2024 Q2
SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION
Q2lda.gov →
2024 Q2
NATIONAL DOWN SYNDROME SOCIETY
Q2lda.gov →
Showing recent filings · full history on lda.gov